| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/BI025605H |
| P698 | PubMed publication ID | 12135371 |
| P2093 | author name string | Daniel E Johnson | |
| Sanjeev Shangary | |||
| P433 | issue | 30 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell death | Q2383867 |
| P304 | page(s) | 9485-9495 | |
| P577 | publication date | 2002-07-01 | |
| P1433 | published in | Biochemistry | Q764876 |
| P1476 | title | Peptides derived from BH3 domains of Bcl-2 family members: a comparative analysis of inhibition of Bcl-2, Bcl-x(L) and Bax oligomerization, induction of cytochrome c release, and activation of cell death | |
| P478 | volume | 41 |
| Q41891155 | An N-terminal region of translationally controlled tumor protein is required for its antiapoptotic activity |
| Q91612741 | Analysis of apoptosis related genes in nurses exposed to anti-neoplastic drugs |
| Q36017772 | Apoptosis-based therapies and drug targets |
| Q36473602 | Apoptotic-induced cleavage shifts HuR from being a promoter of survival to an activator of caspase-mediated apoptosis |
| Q30493313 | Auto-activation of the apoptosis protein Bax increases mitochondrial membrane permeability and is inhibited by Bcl-2 |
| Q24655483 | BH3 mimetics to improve cancer therapy; mechanisms and examples |
| Q41819191 | Bad targets the permeability transition pore independent of Bax or Bak to switch between Ca2+-dependent cell survival and death |
| Q40611422 | Bcl-2 and Bcl-x(L) differentially protect human prostate cancer cells from induction of apoptosis by melanoma differentiation associated gene-7, mda-7/IL-24. |
| Q34611338 | Behavior of solvent-exposed hydrophobic groove in the anti-apoptotic Bcl-XL protein: clues for its ability to bind diverse BH3 ligands from MD simulations |
| Q44494717 | Cyclosporin A inhibits thyroid hormone-induced shortening of the tadpole tail through membrane permeability transition |
| Q36588920 | Delivery of intracellular-acting biologics in pro-apoptotic therapies |
| Q30353924 | Direct Activation of Bax Protein for Cancer Therapy |
| Q36474396 | Effect of Helicobacter pylori infection on expression of Bcl-2 family members in gastric adenocarcinoma |
| Q90799071 | Experimental Characterization of the Binding Affinities between Proapoptotic BH3 Peptides and Antiapoptotic Bcl-2 Proteins |
| Q37239938 | Functional, metal-based crosslinkers for α-helix induction in short peptides |
| Q35679496 | Improving the therapeutic potential of endostatin by fusing it with the BAX BH3 death domain. |
| Q24324220 | Inhibition of mitochondrial neural cell death pathways by protein transduction of Bcl-2 family proteins |
| Q39908819 | Intracellular delivery of a proapoptotic peptide via conjugation to a RAFT synthesized endosomolytic polymer |
| Q35120714 | Mitochondrial membrane permeabilisation by Bax/Bak |
| Q37430520 | Molecular participants in mitochondrial cell death channel formation during neuronal ischemia |
| Q40552534 | Oligomerization of Ebola virus VP30 is essential for viral transcription and can be inhibited by a synthetic peptide |
| Q30971455 | Recent advances in the development of anticancer agents targeting cell death inhibitors in the Bcl-2 protein family |
| Q38989619 | Relationship of Helicobacter pylori to Bcl-2 family expression, DNA content, and pathological characteristics of gastric cancer. |
| Q37119032 | SMI of Bcl-2 TW-37 is active across a spectrum of B-cell tumors irrespective of their proliferative and differentiation status. |
| Q36088627 | Targeting antiapoptotic Bcl-2 family members with cell-permeable BH3 peptides induces apoptosis signaling and death in head and neck squamous cell carcinoma cells. |
| Q36713669 | Targeting proliferation and survival pathways in head and neck cancer for therapeutic benefit |
| Q35831981 | The mitochondrial death pathway: a promising therapeutic target in diseases |
| Q47404782 | The role of Bcl-2 family members in the progression of cutaneous melanoma |
Search more.